As attached

Revenue DeclinePat NegativeRelated Party TransactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹13.00

prior close

₹12.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+0.3% vs market

Pesticides & Agrochemicals peers, median of 24sector+0.6%-0.7% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.7 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1-0.3+0.3+0.6-0.7

Next day

-1.7-0.0-1.7+1.0-2.6

-2.6-1.0-1.6+1.8-4.4

-2.3-1.3-1.0+2.0-4.3

+2.8-3.1+5.9+0.3+2.5

+12.0-2.8+14.8+0.2+11.8

+4.0-2.1+6.1+4.3-0.3

15d

-2.5+1.6-4.0+9.5-11.9

-9.9+1.4-11.4+7.2-17.2

-32.7-2.7-30.0+6.8-39.5

-54.8+0.1-55.0+4.2-59.0

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Natural Biocon (India) Ltd reported its audited financial results for Q4 FY25 and full year FY25. Full year revenue fell sharply to Rs. 834.81 lakhs from Rs. 1,353.37 lakhs in FY24, a decline of about 38%. Q4 FY25 revenue dropped to Rs. 135.14 lakhs compared to Rs. 1,136.95 lakhs in Q4 FY24. The company posted a loss of Rs. 48.62 lakhs in Q4 FY25 against a profit of Rs. 5.86 lakhs in the year-ago quarter. Full year net profit fell to Rs. 4.46 lakhs from Rs. 15.27 lakhs, with diluted EPS at Rs. 0.02. Total assets more than doubled to Rs. 3,852.22 lakhs, mainly due to fresh investments of Rs. 2,112.37 lakhs and an equity share issuance of about Rs. 1,945 lakhs during the year. The statutory auditor M/s Mayur Shah & Associates issued an unmodified (clean) opinion on the results.

Likely market impact

Sharp revenue decline and a Q4 loss are negative signals for shareholders, though the company raised fresh equity capital to fund new investments. Overall earnings quality remains thin and the stock may see pressure given deteriorating operating performance, despite a clean audit opinion.